Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data COMPASS Pathways plc files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2020
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Research and development
12.6
23.4
44
65.1
87.5
119
118
General and administrative
8.62
28
39.2
45.4
49.4
59.2
60.6
Operating expenses
21.2
51.4
83.2
110
137
178
179
Operating income
-21.2
-51.4
-83.2
-110
-137
-178
-179
Interest expense
0
0
2.2
4.48
4.52
Interest income
4.62
8.27
7.18
Other non-operating income
1.58
-8.91
11.7
19.3
19.2
24.7
-111
Pre-tax income
-19.6
-60.3
-71.5
-91.1
-118
-154
-290
Income tax
0.02
0.03
0.2
0.41
0.78
1.59
-2.47
Net income
-19.6
-60.3
-71.7
-91.5
-118
-155
-288
EBITDA
-21.1
-51.3
-83
-110
-137
-178
-179
EPS, basic
-2.62
-3.55
-1.79
-2.16
-2.32
-2.30
-3.08
EPS, diluted
-2.62
-3.55
-1.79
-2.16
-2.32
-2.30
-3.08
Shares, basic (weighted)
7.48
17
40
42.4
51
67.5
93.5
Shares, diluted (weighted)
7.48
17
40
42.4
51
67.5
93.5
Balance sheet
FY2020
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
25
190
273
143
220
165
150
Other current assets
0.74
0.51
1.37
1.04
1.9
3.58
5.58
Total current assets
32.2
202
295
192
261
201
191
Property, plant and equipment
0.22
0.25
0.4
0.62
0.42
0.19
Lease right-of-use assets
3.7
2.01
4.31
2.01
3.42
Other non-current assets
0
0.06
0.21
1.41
7.05
6.6
11.7
Total assets
32.4
203
301
197
276
214
210
Accounts payable
1.26
2.75
2.56
4.76
5.89
12.3
15.2
Accrued liabilities
0.68
1.69
5.02
5.53
7.07
7.91
5.45
Short-term debt
0
5.51
17.5
Total current liabilities
23.9
6.9
15.1
15.6
19.6
34
248
Long-term debt
28.8
24.7
14.1
Lease liabilities
1.38
0.42
1.88
0.3
1.29
Total liabilities
23.9
6.9
16.5
16
50.2
59
263
Total debt
0
28.8
30.2
31.6
Paid-in capital
7.16
279
445
459
622
705
784
Retained earnings
-37.6
-97.9
-170
-261
-380
-535
-823
Other comprehensive income
-0.1
14.6
8.84
-16.9
-16.9
-16.2
-14.8
Shareholders' equity
-30.4
197
284
181
226
155
-52.8
Total equity
-30.4
197
284
181
226
155
-52.8
Total liabilities and equity
32.4
203
301
197
276
214
210
Shares outstanding
61.9
68.6
96.1
Cash flow statement
FY2020
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-19.6
-60.3
-71.7
-91.5
-118
-155
-288
Depreciation and amortization
0.06
0.11
0.18
0.33
0.24
0.23
0.22
Stock-based compensation
3.25
18
8.64
13.1
17.3
19.5
13.6
Deferred income tax
0
-0.22
-0.55
-1.46
-1.11
-0.44
0.02
Change in payables
0.58
1.3
-0.16
2.5
0.86
6.59
2.03
Cash from operations
-17.8
-41.4
-67.7
-105
-97.4
-119
-157
Capital expenditures
-0.17
-0.13
-0.33
-0.6
-0.07
0
Purchases of investments
0
-0.5
0
0
Cash from investing
-0.17
-0.63
-0.33
-0.6
-0.06
0
Debt issued
0
0
29.6
0
Stock issued
0
0
155
0.44
145
26.2
140
Cash from financing
18.4
194
157
1.04
174
63.8
141
Exchange rate effect
1.68
13.2
-5.58
-25
0.87
0.19
1.05
Net change in cash
2.08
165
83
-130
77.3
-55.2
-15.5
Free cash flow
-18
-41.5
-68.1
-106
-97.4
-119
Interest paid
0
0
1.25
3.07
3.05
Income taxes paid
2.44
1.12
0.76
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $13.06 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Return on equity (ROE)
-466.3%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-78.1%
Net income / average total assets.
Growth
Metric
Value
How it is calculated
Book value growth, 1y
-134.2%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
-1.6%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
2.2%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
0.7%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
38.6%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
30.1%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
40.6%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.30x
Current assets / current liabilities.
Quick ratio
1.18x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
1.18x
(Cash + short-term investments) / current liabilities.
Debt / equity
0.60x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
10.1%
Total debt / total assets.
Liabilities / assets
83.2%
Total liabilities / total assets.
Net debt
-$382.6M
Total debt - cash - short-term investments. Negative means more cash than debt.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Operating cash flow per share
-$1.19
Cash from operations / diluted weighted shares.
Book value per share
$0.62
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/B
21.4x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
21.4x
Market cap / tangible book value, when positive.
Earnings yield
-21.8%
Net income / market cap (the inverse of P/E).
Was COMPASS Pathways plc profitable in fiscal 2025?
No. It reported a net loss of $287.9M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.